A Polish population-based study examined the prevalence of the E318K and V320I MITF mutation germline in cancer patients and its association with the risk of cancers of different sites, such as melanoma or kidney, lung, prostate, colon or breast cancer. This evidence concerns the gene MITF and cancer.